Sec. 431.183. FALSE ADVERTISEMENT OF DRUG OR DEVICE. (a) An advertisement of a drug or device is false if the advertisement represents that the drug or device affects:
(1) infectious and parasitic diseases;
(2) neoplasms;
(3) endocrine, nutritional, and metabolic diseases and immunity disorders;
(4) diseases of blood and blood-forming organs;
(5) mental disorders;
(6) diseases of the nervous system and sense organs;
(7) diseases of the circulatory system;
(8) diseases of the respiratory system;
(9) diseases of the digestive system;
(10) diseases of the genitourinary system;
(11) complications of pregnancy, childbirth, and the puerperium;
(12) diseases of the skin and subcutaneous tissue;
(13) diseases of the musculoskeletal system and connective tissue;
(14) congenital anomalies;
(15) certain conditions originating in the perinatal period;
(16) symptoms, signs, and ill-defined conditions; or
(17) injury and poisoning.
(b) Subsection (a) does not apply to an advertisement of a drug or device if the advertisement does not violate Section 431.182 and is disseminated:
(1) to the public for self-medication and is consistent with the labeling claims permitted by the federal Food and Drug Administration;
(2) only to members of the medical, dental, and veterinary professions and appears only in the scientific periodicals of those professions; or
(3) only for the purpose of public health education by a person not commercially interested, directly or indirectly, in the sale of the drug or device.
(c) The executive commissioner by rule shall authorize the advertisement of a drug having a curative or therapeutic effect for a disease listed under Subsection (a) if the executive commissioner determines that an advance in medical science has made any type of self-medication safe for the disease. The executive commissioner may impose conditions and restrictions on the advertisement of the drug necessary in the interest of public health.
(d) This section does not indicate that self-medication for a disease other than a disease listed under Subsection (a) is safe or effective.
Acts 1989, 71st Leg., ch. 678, Sec. 1, eff. Sept. 1, 1989. Amended by Acts 1991, 72nd Leg., ch. 14, Sec. 160, eff. Sept. 1, 1991.
Amended by:
Acts 2015, 84th Leg., R.S., Ch. 1 (S.B. 219), Sec. 3.0977, eff. April 2, 2015.
Copyright ©2024 LegalFix. All rights reserved. LegalFix is not a law firm, is not licensed to practice law, and does not provide legal advice, services, or representation. The information on this website is an overview of the legal plans you can purchase—or that may be provided by your employer as an employee benefit or by your credit union or other membership group as a membership benefit.
LegalFix provides its members with easy access to affordable legal services through a network of independent law firms. LegalFix, its corporate entity, and its officers, directors, employees, agents, and contractors do not provide legal advice, services, or representation—directly or indirectly.
The articles and information on the site are not legal advice and should not be relied upon—they are for information purposes only. You should become a LegalFix member to get legal services from one of our network law firms.
You should not disclose confidential or potentially incriminating information to LegalFix—you should only communicate such information to your network law firm.
The benefits and legal services described in the LegalFix legal plans are not always available in all states or with all plans. See the legal plan Benefit Overview and the more comprehensive legal plan contract during checkout for coverage details in your state.
Use of this website, the purchase of legal plans, and access to the LegalFix networks of law firms are subject to the LegalFix Terms of Service and Privacy Policy.